Stay updated with breaking news from Interventional Urology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) was the recipient of a significant increase in short interest in May. As of May 15th, there was short interest totalling 943,900 shares, an increase of 10.9% from the April 30th total of 850,900 shares. Based on an average trading volume of 200 shares, the short-interest ratio is […]
Haemonetics (NYSE:HAE – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent ratings […]
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Bone Biologics (NASDAQ:BBLG – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent […]
Bone Biologics (NASDAQ:BBLG – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Profitability This table compares Bone Biologics and Coloplast […]
H1 2023/24Interim financial results, H1 2023/241 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT...